
JW (Cayman) Therapeutics Co Ltd
HKEX:2126

Intrinsic Value
The intrinsic value of one
JW (Cayman) Therapeutics Co Ltd
stock under the Base Case scenario is
7.12
HKD.
Compared to the current market price of 1.73 HKD,
JW (Cayman) Therapeutics Co Ltd
is
Undervalued by 76%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
JW (Cayman) Therapeutics Co Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
JW (Cayman) Therapeutics Co Ltd
Balance Sheet Decomposition
JW (Cayman) Therapeutics Co Ltd
Current Assets | 808.7m |
Cash & Short-Term Investments | 757.4m |
Receivables | 7.2m |
Other Current Assets | 44.1m |
Non-Current Assets | 871.7m |
PP&E | 275.5m |
Intangibles | 583m |
Other Non-Current Assets | 13.2m |
Free Cash Flow Analysis
JW (Cayman) Therapeutics Co Ltd
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
JW (Cayman) Therapeutics Co Ltd
Revenue
|
158.2m
CNY
|
Cost of Revenue
|
-80.9m
CNY
|
Gross Profit
|
77.3m
CNY
|
Operating Expenses
|
-536.3m
CNY
|
Operating Income
|
-459m
CNY
|
Other Expenses
|
-131.6m
CNY
|
Net Income
|
-590.6m
CNY
|
Profitability Score
Profitability Due Diligence
JW (Cayman) Therapeutics Co Ltd's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

Score
JW (Cayman) Therapeutics Co Ltd's profitability score is 30/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
JW (Cayman) Therapeutics Co Ltd's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Score
JW (Cayman) Therapeutics Co Ltd's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
JW (Cayman) Therapeutics Co Ltd
Dividends
Current shareholder yield for JW (Cayman) Therapeutics Co Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
JW (Cayman) Therapeutics Co Ltd
stock under the Base Case scenario is
7.12
HKD.
Compared to the current market price of 1.73 HKD,
JW (Cayman) Therapeutics Co Ltd
is
Undervalued by 76%.